缺血性卒中TIA二级预防中的他汀使用培训.ppt

Amedicalguideline(alsocalledaclinicalguideline,clinicalprotocolorclinicalpracticeguideline)isadocumentwiththeaimofguidingdecisionsandcriteriaregardingdiagnosis,management,andtreatmentinspecificareasofhealthcare.;2025/4/3;ANewErainSecondaryStrokePrevention

???

Updated:May19,2014

ANewErainSecondaryStrokePrevention

Disclosure: Dr.Kim-TenserandDr.Mackhavenorelevantdisclosures.

PubDate: Thursday,?May1,2014

Authors: MayKim-Tenser,MD,andWilliamJ.Mack,MD,MS,FAANS,FAHA

Affiliation:? UniversityofSouthernCalifornia/KeckSchoolofMedicine ;不同角度看到问题不同;对卒中二级预防他汀指南影响的里程碑;对卒中二级预防他汀指南影响的里程碑;二级预防中的他汀治疗奠基石;Meanon-treatmentLDL-C:

Placebo=129mg/dL

Atorvastatin=73mg/dL;HR=0.67(95%CI0.47,0.94),P=.02*;Note:PercentchangeeffectsfromCoxproportionalhazardsmodelswithadjustmentforgenderandbaselineagewithreferencegroup=nochangeorincrease;Note:NominalvalueeffectsfromCoxproportionalhazardsmodelswithadjustmentforgenderandbaselineagewithreferencegroup=nochangeorincrease;对卒中二级预防他汀指南影响的里程碑;MeasuringEffectsofIntima-MediaThickness:

AnEvaluationofRosuvastatin;METEOR:目的;METEOR:研究设计;METEORTrial：血脂变化;颈动脉CIMT变化(mm/year);*CrouseJRIIIetal.JAMA2007;297(12):1344-1353;颈总动脉CMIT变化(mm/year);颈动脉球部CIMT(mm/year);颈内动脉CIMT变化(mm/year);WILMINGTON,Del.,November09,2007/PRNewswire-FirstCall/--AstraZenecaannouncedtodaythattheU.S.FoodandDrugAdministration(FDA)hasapprovedCrestor(rosuvastatincalcium)asanadjuncttodiettoslowtheprogressionofatherosclerosisinpatientswithelevatedcholesterol.ThisnewindicationgivesCrestoranimportantdifferentiatorfromcompetitorsinthecholesterol-loweringmarketplace.;陈韵岱;对卒中二级预防他汀指南影响的里程碑;2011年AHA/ASA卒中二级预防指南：

强化降脂，达标“5018”;对卒中二级预防他汀指南影响的里程碑;

StentingandAggressiveMedicalManagementforPreventingRecurrentstrokeinIntracranialStenosis

颅内动脉狭窄为预防再发卒中

的支架和积极药物治疗

;SAMMPRIS设计;SAMMP